entertainment -WSS

entertainment

author：explore 2025-08-12 09:09:45 - browse：87

A person uses continuous glucose remote monitor with his phone — health tech coverage from STAT — Adobe

A diabetes diagnosis was not what Jason had in mind when he set out on a cross-country road trip with his family in the fall of 2021. He had been heavy since he was a kid, but he always had felt pretty healthy — until getting home to the San Francisco Bay Area, when he started to notice his body doing strange things.

“It kind of came out of nowhere,” said Jason, who asked to keep his last name private. All of a sudden, he had to get up to pee five times in a night. Just a few weeks after his trip, he was having a hard time walking around the block. He went to get checked out at the Palo Alto Medical Foundation, and on a Thursday night in November, the blood test results popped up in his patient portal: He had type 2 diabetes.

“I was freaked out,” he said. “I was in legitimately bad shape.” It would take months to see an endocrinologist. So that day, he signed up to try a novel, telehealth-based approach for managing diabetes with a young company called Steady Health. Jason knew the company through his Bay Area startup connections — as well as Carbon Health, the primary care startup, reportedly valued at more than $3 billion, that had recently acquired Steady.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： How to convince healthy people to buy insurance

WSS

Gene therapy’s promise and the high cost of hope

First U.S. drug developed to treat liver disease MASH is approved

Medicare must police algorithms in Medicare Advantage, Dems say

Readout Newsletter: CAR

Male and female sex labels in research insufficient, scientists say

DeepMind touts AlphaFold's new skills as protein folding AI models face off

hotspot

entertainment

explore

23andMe had bad news about my health. I wish a person had delivered it

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Continuity nursing helped my family in our darkest PICU moments

Male and female sex labels in research insufficient, scientists say

United colonoscopy coverage change 'may cost lives,' doctors say

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Malaria cases in Florida and Texas: Here’s what you need to know

Readout LOUD podcast: ESMO highlights & Roivant's big deal

State Dept. review finds Biden bears some blame for Afghanistan failures

Infant mortality in U.S. rose last year for first time in decades: CDC

focus

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

After Sarepta trial failure, Duchenne families brace for more debate

What is microchimerism and how does it affect maternal health?

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

Brain injuries and the importance of a second opinion

Prime Medicine says its gene editing passes test in monkeys

knowledge

hotspot

hotspot

hotspot